Lawyers for plaintiffs who have linked talcum powder to ovarian cancer are beginning to push back against the mass removal of their cases from state to federal court in the wake of the bankruptcy filing of a major talc supplier.
The filing earlier this year for bankruptcy protection of Imerys, the talc supplier to Johnson & Johnson, led the consumer products manufacturer to remove to federal court thousands of talc cases—many of which had been gearing up for trial.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
